<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Robotic surgery</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Xcath sees Iris robotic platform transforming stroke treatment</title>
      <description>
        <![CDATA[As robotic-assisted surgery platforms increasingly demonstrate that they can perform telesurgery safely, the question now is how soon remote operations will become part of routine clinical care. Eduardo Fonseca, CEO of Xcath Robotics Inc., reckons that within a decade the company’s Iris Surgical Robotic System could be in widespread use.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729916</guid>
      <pubDate>Fri, 27 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729916-xcath-sees-iris-robotic-platform-transforming-stroke-treatment</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2026/XCath-telesurgery-hero-3-27-26.webp?t=1774644243" type="image/jpeg" medium="image" fileSize="706985">
        <media:title type="plain">Xcath Team Santiago Control Room</media:title>
        <media:description type="plain">Neurosurgeon Dr. Vitor Mendes Pereira controlling the telesurgery system and Dr. Fred Moll, chairman of Xcath, in the Santiago control room. Credit: Xcath Robotics Inc.
</media:description>
      </media:content>
    </item>
    <item>
      <title>How to grow a startup in the AI era: MedTech Spotlight Korea 2026 </title>
      <description>
        <![CDATA[AI and advanced biotechnology are reshaping South Korea’s med-tech sector, but great technology alone is not enough to build a successful medical device company, speakers said at MedTech Innovator’s Medtech Spotlight: New Impact Korea 2026.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729896</guid>
      <pubDate>Tue, 24 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729896-how-to-grow-a-startup-in-the-ai-era-medtech-spotlight-korea-2026</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Newco/AI-startup-art-concept.webp?t=1774299523" type="image/jpeg" medium="image" fileSize="387241">
        <media:title type="plain">AI startup art concept</media:title>
      </media:content>
    </item>
    <item>
      <title>CMR works with Nvidia to transform surgical robotics platforms</title>
      <description>
        <![CDATA[CMR Surgical Ltd.’s participation in Nvidia’s Physical AI health care robotics initiative is expected to accelerate the development of the next generation of intelligent surgical robotic systems powered by data, simulation and AI. As demand for minimally invasive procedures grows, more companies are entering the surgical robotics space.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729827</guid>
      <pubDate>Tue, 24 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729827-cmr-works-with-nvidia-to-transform-surgical-robotics-platforms</link>
      <media:content url="https://www.bioworld.com/ext/resources/BW-source/2026/CMR-Versius-Plus-System-3-24.webp?t=1774385235" type="image/jpeg" medium="image" fileSize="238929">
        <media:title type="plain">CMR Versius Plus System</media:title>
        <media:description type="plain">Versius Plus surgical robotic system. Credit: CMR Surgical Ltd.</media:description>
      </media:content>
    </item>
    <item>
      <title>How to grow a startup in the AI era: MedTech Spotlight Korea 2026 </title>
      <description>
        <![CDATA[AI and advanced biotechnology are reshaping South Korea’s med-tech sector, but great technology alone is not enough to build a successful medical device company, speakers said at MedTech Innovator’s Medtech Spotlight: New Impact Korea 2026.]]>
      </description>
      <guid>http://www.bioworld.com/articles/729811</guid>
      <pubDate>Mon, 23 Mar 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/729811-how-to-grow-a-startup-in-the-ai-era-medtech-spotlight-korea-2026</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Newco/AI-startup-art-concept.webp?t=1774299523" type="image/jpeg" medium="image" fileSize="387241">
        <media:title type="plain">AI startup art concept</media:title>
      </media:content>
    </item>
    <item>
      <title>F.Med redefines the future of microsurgical robotics</title>
      <description>
        <![CDATA[Microsurgery is performed to connect small human vessels, but the technical difficulty required to conduct this type of surgery is quite specialized and limits the number of surgeons who can perform microsurgery.]]>
      </description>
      <guid>http://www.bioworld.com/articles/728065</guid>
      <pubDate>Wed, 21 Jan 2026 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/728065-fmed-redefines-the-future-of-microsurgical-robotics</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2026/F-med-prototype-mini-robot-21jan26.webp?t=1769029966" type="image/jpeg" medium="image" fileSize="77052">
        <media:title type="plain">F-med prototype mini robot</media:title>
        <media:description type="plain">F.Med’s microsurgery robot prototype. Credit: F.Med</media:description>
      </media:content>
    </item>
    <item>
      <title>Distalmotion secures investment from J&amp;J for Dexter</title>
      <description>
        <![CDATA[Distalmotion SA recently secured a strategic investment from Johnson & Johnson for its robotic-assisted surgical system Dexter, amid an increase in demand from ambulatory surgery centers for such platforms. The deal follows Distalmotion’s $150 million in a series G financing, and coincides with J&J’s recent submission of its own robotic surgical system, Ottava, to the U.S. FDA., for clearance.]]>
      </description>
      <guid>http://www.bioworld.com/articles/727832</guid>
      <pubDate>Thu, 15 Jan 2026 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/727832-distalmotion-secures-investment-from-j-and-j-for-dexter</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2026/Distalmotion-Dexter-Surgical-Robot-15jan26.webp?t=1768514470" type="image/jpeg" medium="image" fileSize="176296">
        <media:title type="plain">Distalmotion Dexter Surgical Robot</media:title>
        <media:description type="plain">Distalmotion Dexter robotic-assisted surgical system. Credit: Distalmotion</media:description>
      </media:content>
    </item>
    <item>
      <title>Surgical robotic maker Shenzhen Edge announces $154M HKEX IPO</title>
      <description>
        <![CDATA[Surgical robotics maker Shenzhen Edge Medical Co. Ltd. reported its initial public offering on the Hong Kong Stock Exchange to raise HKD$1.19 billion (US$154 million) to advance its pipeline of surgical robotic systems and expand its geographic footprint to markets outside China.]]>
      </description>
      <guid>http://www.bioworld.com/articles/727307</guid>
      <pubDate>Wed, 31 Dec 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/727307-surgical-robotic-maker-shenzhen-edge-announces-154m-hkex-ipo</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Shenzhen-Edge-Medical-Co.-Ltd.-Multi-Port-Endoscopic-Surgical-Robot-12-31.webp?t=1767210534" type="image/jpeg" medium="image" fileSize="208812">
        <media:title type="plain">Shenzhen Edge Medical Co. Ltd.’s Multi-Port Endoscopic Surgical Robot</media:title>
        <media:description type="plain">Shenzhen Edge Medical Co. Ltd.’s Multi-Port Endoscopic Surgical Robot</media:description>
      </media:content>
    </item>
    <item>
      <title>Intuitive sees continued da Vinci growth amid rising competition</title>
      <description>
        <![CDATA[Intuitive Surgical Inc. strengthened its position as the market leader in robotic-assisted surgery in 2025 on the back of increasing demand for minimally invasive procedures. Intuitive’s da Vinci system is seeing robust growth in procedures and installations, fueling increased revenues.]]>
      </description>
      <guid>http://www.bioworld.com/articles/727297</guid>
      <pubDate>Tue, 30 Dec 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/727297-intuitive-sees-continued-da-vinci-growth-amid-rising-competition</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2020/1-24-intuitive-da-vinci-surgeon.webp?t=1602106612" type="image/png" medium="image" fileSize="1745496">
        <media:title type="plain">Surgeon at workstation for surgical robot</media:title>
        <media:description type="plain">Da Vinci surgical system. Credit: Intuitive Surgical Inc.</media:description>
      </media:content>
    </item>
    <item>
      <title>Medtronic’s Hugo robotic system gets FDA nod</title>
      <description>
        <![CDATA[The U.S. FDA’s clearance of Medtronic plc’s Hugo robotic-assisted surgery (RAS) system is certainly a boon for the company which is betting on the unit to be a key growth driver. While the soft tissue robotics market is dominated by Intuitive Surgical Inc.’s da Vinci system, the space is growing, and Medtronic has the scale, resources and market presence to make headway but there are also a plethora of smaller, versatile and cost-effective systems looking for a piece of the pie.]]>
      </description>
      <guid>http://www.bioworld.com/articles/726721</guid>
      <pubDate>Mon, 08 Dec 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726721-medtronics-hugo-robotic-system-gets-fda-nod</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Medtronic-Hugo-platform-22aug25.webp?t=1771530746" type="image/jpeg" medium="image" fileSize="419119">
        <media:title type="plain">Medtronic Hugo platform</media:title>
        <media:description type="plain">Medtronic Hugo robotic-assisted surgery (RAS) system. Credit: Medtronic</media:description>
      </media:content>
    </item>
    <item>
      <title>SS Innovations SSi Mantra surgical robot sees increasing demand</title>
      <description>
        <![CDATA[SS Innovations International Inc. is experiencing rapid growth and rising demand for its SSi Mantra 3 surgical robotic system. Its revenues are increasing, and so are installations and procedures driven by the design features and affordability of the SSi Mantra, said Sudhir Srivastava, chairman of the board and CEO of SS Innovations. “The system that we have created is, in my personal opinion, better than anything that exists out there because of its various differentiating features and cost effectiveness,” he told BioWorld.]]>
      </description>
      <guid>http://www.bioworld.com/articles/726443</guid>
      <pubDate>Tue, 02 Dec 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726443-ss-innovations-ssi-mantra-surgical-robot-sees-increasing-demand</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/SSi-Mantra-3-surgical-robotic-system-2dec25.webp?t=1764710740" type="image/jpeg" medium="image" fileSize="206655">
        <media:title type="plain">SS Innovations International Inc. SSi Mantra 3 robotic surgical system</media:title>
        <media:description type="plain">SSi Mantra 3 robotic surgical system. Credit: SS Innovations International Inc.</media:description>
      </media:content>
    </item>
    <item>
      <title>ARPA-H sees a bright future for autonomous surgery microbots</title>
      <description>
        <![CDATA[The Advanced Research Projects Agency for Health (ARPA-H) is taking aim at the shortage of medical services with a program designed to foster development of micro-robots, or microbots, which will autonomously conduct part or all of a variety of surgical procedures.]]>
      </description>
      <guid>http://www.bioworld.com/articles/726396</guid>
      <pubDate>Tue, 25 Nov 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726396-arpa-h-sees-a-bright-future-for-autonomous-surgery-microbots</link>
      <media:content url="https://www.bioworld.com/ext/resources/BWS/BWS-source/IBEC-nanobots-accumulation.webp?t=1706543308" type="image/jpeg" medium="image" fileSize="156031">
        <media:title type="plain">Accumulation of nanorobots in a bladder tumor by microscopy.</media:title>
        <media:description type="plain">Accumulation of nanorobots in a bladder tumor by microscopy. Credit: IBEC Barcelona.</media:description>
      </media:content>
    </item>
    <item>
      <title>CMR Surgical targets US with Versius Plus robotic system</title>
      <description>
        <![CDATA[CMR Surgical Ltd. hopes to soon gain U.S. FDA 510(k) clearance for its Versius Plus surgical robotic system to bring it to the U.S. market amid rising demand for robotic surgery. Although the company’s original Versius system received FDA clearance in 2024 for use in cholecystectomy in adults, CMR waited to bring the enhanced Versius Plus model to market instead. “I have such a respect for the U.S. market that the last thing that I would do is to enter a market with a product that is outdated,” Massimiliano Colella, CMR CEO told <em>BioWorld</em>.]]>
      </description>
      <guid>http://www.bioworld.com/articles/726386</guid>
      <pubDate>Mon, 24 Nov 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/726386-cmr-surgical-targets-us-with-versius-plus-robotic-system</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/CMR-Surgical-Versius-system-24nov25.webp?t=1764014372" type="image/jpeg" medium="image" fileSize="347530">
        <media:title type="plain">CMR Surgical Versius surgical robotic system</media:title>
        <media:description type="plain">CMR Surgical Versius surgical robotic system. Credit: CMR Surgical</media:description>
      </media:content>
    </item>
    <item>
      <title>China’s Cornerstone Robotics raises $200M series D round</title>
      <description>
        <![CDATA[Cornerstone Robotics Ltd. raised an oversubscribed $200 million series D round to accelerate commercialization of its flagship product, the Sentire Endoscopic Surgical System.]]>
      </description>
      <guid>http://www.bioworld.com/articles/725991</guid>
      <pubDate>Fri, 14 Nov 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/725991-chinas-cornerstone-robotics-raises-200m-series-d-round</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Cornerstone-Robotics-Sentire-Surgical-System-12nov25.webp?t=1763154095" type="image/jpeg" medium="image" fileSize="147992">
        <media:title type="plain">Cornerstone Robotics Sentire Surgical System</media:title>
        <media:description type="plain">Cornerstone Robotics Sentire Surgical System. Credit: Cornerstone Robotics Ltd.</media:description>
      </media:content>
    </item>
    <item>
      <title>Quantum Surgical gets CE mark for Epione</title>
      <description>
        <![CDATA[Quantum Surgical SAS has secured CE marking for the expanded use of its Epione robotic platform to treat bone tumors and metastases. The regulatory green light allows surgeons to use Epione to treat inoperable tumors which are difficult to reach due to their size or location at an early stage, in a simple and effective way.]]>
      </description>
      <guid>http://www.bioworld.com/articles/723570</guid>
      <pubDate>Thu, 04 Sep 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723570-quantum-surgical-gets-ce-mark-for-epione</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Quantum-Surgical-Epione-robotic-platform-4sept25.webp?t=1757021189" type="image/jpeg" medium="image" fileSize="346410">
        <media:title type="plain">Quantum Surgical Epione robotic platform</media:title>
        <media:description type="plain">Quantum Surgical Epione robotic platform. Credit: Quantum Surgical</media:description>
      </media:content>
    </item>
    <item>
      <title>Medtronic expects Hugo robotic system to drive growth</title>
      <description>
        <![CDATA[Medtronic plc expects its Hugo robotic-assisted surgery system to be a key growth driver, especially when it receives U.S. FDA approval. Already approved for use in Europe, Medtronic recently received CE mark for the Ligasure technology to be used with the Hugo RAS system, expanding its capabilities for gynecologic, general and urologic procedures, across the region.]]>
      </description>
      <guid>http://www.bioworld.com/articles/723206</guid>
      <pubDate>Fri, 22 Aug 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/723206-medtronic-expects-hugo-robotic-system-to-drive-growth</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Medtronic-Hugo-platform-22aug25.webp?t=1771530746" type="image/jpeg" medium="image" fileSize="419119">
        <media:title type="plain">Medtronic Hugo platform</media:title>
        <media:description type="plain">Medtronic Hugo robotic-assisted surgery (RAS) system. Credit: Medtronic</media:description>
      </media:content>
    </item>
    <item>
      <title> Olympus co-launches Swan as new JV for endoluminal GI robotics</title>
      <description>
        <![CDATA[Olympus Corp.’s “active investment” in endoluminal robotics has materialized in a new joint venture med-tech called Swan Endosurgical Inc., with Revival Healthcare Capital LLC.]]>
      </description>
      <guid>http://www.bioworld.com/articles/722652</guid>
      <pubDate>Tue, 05 Aug 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/722652-olympus-co-launches-swan-as-new-jv-for-endoluminal-gi-robotics</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Deals-and-MAs/Merger-puzzle-pieces-arrow-hands.webp?t=1644441920" type="image/png" medium="image" fileSize="99873">
        <media:title type="plain">Hands holding arrow-shaped puzzle pieces</media:title>
      </media:content>
    </item>
    <item>
      <title>Zimmer Biomet in $168M buy of ortho robotics maker Monogram</title>
      <author>holland.johnson@clarivate.com</author>
      <description>
        <![CDATA[Zimmer Biomet Holdings Inc. reported it is buying orthopedic robotics maker Monogram Technologies Inc. for an upfront payment of $4.04 per share in cash, corresponding to an equity value of approximately $177 million and an enterprise value of about $168 million. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/721943</guid>
      <pubDate>Mon, 14 Jul 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/721943-zimmer-biomet-in-168m-buy-of-ortho-robotics-maker-monogram</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Deals-and-MAs/Stock-merger-illustration.webp?t=1620238968" type="image/png" medium="image" fileSize="458135">
        <media:title type="plain">Stock merger illustration</media:title>
      </media:content>
    </item>
    <item>
      <title>Forsight Robotics secures $125M for eye surgery robotics platform</title>
      <description>
        <![CDATA[Forsight Robotics Ltd. secured $125 million in series B financing for its Oryom platform, a robotic system for cataract surgery.]]>
      </description>
      <guid>http://www.bioworld.com/articles/721248</guid>
      <pubDate>Fri, 27 Jun 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/721248-forsight-robotics-secures-125m-for-eye-surgery-robotics-platform</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Ocular/Close-up-of-eye-and-vision-test.webp?t=1730493501" type="image/jpeg" medium="image" fileSize="159676">
        <media:title type="plain">Close up of eye and vision test</media:title>
      </media:content>
    </item>
    <item>
      <title>Alexandra Hospital team patents new AI robotic knee surgery</title>
      <description>
        <![CDATA[A research team led by consultant and orthopedic surgeon Glen Liau Zi Qiang from Alexandra Hospital in Singapore developed a new AI algorithm to improve the accuracy and efficiency of robotic total knee arthroplasty (rTKA) surgery.]]>
      </description>
      <guid>http://www.bioworld.com/articles/720634</guid>
      <pubDate>Tue, 03 Jun 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/720634-alexandra-hospital-team-patents-new-ai-robotic-knee-surgery</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/AI-knee-surgery-AlexandraHospital-3june25.webp?t=1748983077" type="image/jpeg" medium="image" fileSize="754949">
        <media:title type="plain">AI knee surgery at Alexandra Hospital</media:title>
        <media:description type="plain">A team of medical programmers from Alexandra Hospital in Singapore showcase their patented novel AI-based algorithm for robotic total knee arthroplasty surgery. Left to right: Glen Liau, Ryan Loke and Matthew Ng.
</media:description>
      </media:content>
    </item>
    <item>
      <title>FDA greenlights Distalmotion’s Dexter for gallbladder removal</title>
      <description>
        <![CDATA[The U.S. FDA granted 510(k) clearance to Distalmotion SA's Dexter, its surgical robotic system, for use in cholecystectomy in adults. The greenlight from the regulatory body is the second nod Dexter has received following de novo clearance granted in 2024 for use in inguinal hernia repair.]]>
      </description>
      <guid>http://www.bioworld.com/articles/720418</guid>
      <pubDate>Thu, 29 May 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/720418-fda-greenlights-distalmotions-dexter-for-gallbladder-removal</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2021/01-05-Distalmotion-Dexter.webp?t=1609885240" type="image/png" medium="image" fileSize="365409">
        <media:title type="plain">Product image</media:title>
        <media:description type="plain">The Dexter surgical robot. Credit: Distalmotion SA</media:description>
      </media:content>
    </item>
    <item>
      <title>J&amp;J reports completion of first cases with Ottava robotic system</title>
      <author>holland.johnson@clarivate.com</author>
      <description>
        <![CDATA[Johnson & Johnson’s Medtech division reported the completion of the first cases in the clinical trial for the Ottava robotic surgical system. The cases mark the first clinical experience with the Ottava system, which has been a long time in development. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/719131</guid>
      <pubDate>Tue, 15 Apr 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/719131-j-and-j-reports-completion-of-first-cases-with-ottava-robotic-system</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2023/1-26--Da-Vinci-Xi-robot-Intuitive-Surgical.webp?t=1744749714" type="image/png" medium="image" fileSize="1246255">
        <media:title type="plain">Da Vinci Xi robot - Intuitive Surgical</media:title>
        <media:description type="plain">The updated Ottava will feature four arms, like competitor Da Vinci Xi robot (pictured) from Intuitive Surgical. Credit: Intuitive Surgical Inc.</media:description>
      </media:content>
    </item>
    <item>
      <title>CMR Surgical hauls in $200M to take surgical robot to the US</title>
      <description>
        <![CDATA[CMR Surgical Ltd. secured more than $200 million in funding to bring its surgical robotic system, Versius, to the U.S. market and expand elsewhere. The financing, which came in the form of equity and debt, is “highly important” for the company and comes at the right time as it is “expanding and growing nicely,” company CEO Massimiliano Colella told BioWorld.]]>
      </description>
      <guid>http://www.bioworld.com/articles/718645</guid>
      <pubDate>Wed, 02 Apr 2025 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/718645-cmr-surgical-hauls-in-200m-to-take-surgical-robot-to-the-us</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/CMR-Surgical-Versius-system-2apr25.webp?t=1743626691" type="image/jpeg" medium="image" fileSize="347530">
        <media:title type="plain">CMR Surgical Versius system</media:title>
        <media:description type="plain">CMR Surgical Versius robotic system. Credit: CMR Surgical</media:description>
      </media:content>
    </item>
    <item>
      <title>Astellas-Yaskawa JV to build robot-based cell production platform</title>
      <description>
        <![CDATA[Astellas Pharma Inc. is setting up a joint venture with Yaskawa Electric Corp. to develop a new cell production platform using Yaskawa’s dual-arm humanoid robot called Maholo. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/718192</guid>
      <pubDate>Tue, 11 Mar 2025 11:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/718192-astellas-yaskawa-jv-to-build-robot-based-cell-production-platform</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Astellas-Yaskawa-Maholo1-6mar25.webp?t=1741299688" type="image/jpeg" medium="image" fileSize="203795">
        <media:title type="plain">Astellas Yaskawa Maholo</media:title>
        <media:description type="plain">Astellas Yaskawa Maholo. Credit: Astellas, Yaskawa</media:description>
      </media:content>
    </item>
    <item>
      <title>Astellas-Yaskawa JV to build robot-based cell production platform</title>
      <description>
        <![CDATA[Astellas Pharma Inc. is setting up a joint venture with Yaskawa Electric Corp. to develop a new cell production platform using Yaskawa’s dual-arm humanoid robot called Maholo. ]]>
      </description>
      <guid>http://www.bioworld.com/articles/717733</guid>
      <pubDate>Thu, 06 Mar 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/717733-astellas-yaskawa-jv-to-build-robot-based-cell-production-platform</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Astellas-Yaskawa-Maholo1-6mar25.webp?t=1741299688" type="image/jpeg" medium="image" fileSize="203795">
        <media:title type="plain">Astellas Yaskawa Maholo</media:title>
        <media:description type="plain">Astellas Yaskawa Maholo. Credit: Astellas, Yaskawa</media:description>
      </media:content>
    </item>
    <item>
      <title>Cardiovascular, robotics and AI attract European VCs</title>
      <description>
        <![CDATA[Med-tech companies focusing on cardiovascular diseases or neurological conditions, women’s health or robotic surgery, will find European investors willing to deploy capital into their stories. European venture capital firms are excited about the continuing innovation and opportunities in the sector.]]>
      </description>
      <guid>http://www.bioworld.com/articles/717161</guid>
      <pubDate>Wed, 19 Feb 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/717161-cardiovascular-robotics-and-ai-attract-european-vcs</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Money/Tinted-Euro-symbol.webp?t=1685996236" type="image/jpeg" medium="image" fileSize="59509">
        <media:title type="plain">Tinted Euro symbol</media:title>
      </media:content>
    </item>
    <item>
      <title>Microport’s laparoscopic surgical robot cleared in China</title>
      <description>
        <![CDATA[Shanghai Microport Medbot (Group) Co. Ltd. won China National Medical Products Administration approval of its self-developed Toumai single-arm and single-port laparoscopic surgical robot.]]>
      </description>
      <guid>http://www.bioworld.com/articles/716936</guid>
      <pubDate>Fri, 14 Feb 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/716936-microports-laparoscopic-surgical-robot-cleared-in-china</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Regulatory/Wooden-stamp-with-China-flag.webp?t=1728932051" type="image/jpeg" medium="image" fileSize="185893">
        <media:title type="plain">Wooden stamp with China flag</media:title>
      </media:content>
    </item>
    <item>
      <title>Cornerstone Robotics raises $70M to expand international footprint</title>
      <description>
        <![CDATA[Cornerstone Robotics Ltd. raised more than $70 million in a series C round to expand its international footprint and accelerate R&D efforts for its robotic surgery solutions.&nbsp;<span style=" font-style: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; widows: 2; word-spacing: 0px; display: inline !important; float: none;">The funds will allow the Hong Kong-headquartered company to accelerate commercialization of new surgical robotic products, conduct clinical trials, obtain regulatory approvals and promote global adoption of advanced robotic surgical solutions. </span>
]]>
      </description>
      <guid>http://www.bioworld.com/articles/715979</guid>
      <pubDate>Tue, 14 Jan 2025 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/715979-cornerstone-robotics-raises-70m-to-expand-international-footprint</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2025/Cornerstone-Robotics-Sentire-14jan25.webp?t=1736892217" type="image/jpeg" medium="image" fileSize="124041">
        <media:title type="plain">Cornerstone Robotics Sentire</media:title>
        <media:description type="plain">Sentire endoscopic robot. Credit: Cornerstone Robotics Ltd.</media:description>
      </media:content>
    </item>
    <item>
      <title>China clears Stereotaxis/Microport’s robotic ablation catheter</title>
      <description>
        <![CDATA[Stereotaxis Inc. and Chinese partner Shanghai Microport EP Medtech Co. Ltd. gained the National Medical Products Administration’s approval of its Magbot magnetic navigation ablation catheter Dec. 9 for use with Stereotaxis’ robotic ablation system to treat drug-resistant cardiac arrhythmias in China.]]>
      </description>
      <guid>http://www.bioworld.com/articles/715099</guid>
      <pubDate>Wed, 11 Dec 2024 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/715099-china-clears-stereotaxis-microports-robotic-ablation-catheter</link>
      <media:content url="https://www.bioworld.com/ext/resources/Stock-images/Therapeutic-topics/Cardiovascular/heart-cardio-data.webp?t=1705604213" type="image/png" medium="image" fileSize="343935">
        <media:title type="plain">Blue heart and data grid</media:title>
      </media:content>
    </item>
    <item>
      <title>Momentis gains FDA clearance for second generation surgical robot</title>
      <description>
        <![CDATA[Momentis Surgical Ltd. received 510 (k) clearance from the U.S. FDA for the second-generation of the Anovo robotic surgical platform. The upgraded system allows surgeons to experience enhanced ergonomics with integrated haptic feedback, creating more intuitive control of the robotic arms during surgical procedures.]]>
      </description>
      <guid>http://www.bioworld.com/articles/714037</guid>
      <pubDate>Tue, 12 Nov 2024 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/714037-momentis-gains-fda-clearance-for-second-generation-surgical-robot</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2024/Momentis-Surgical-robotic-platform-2-12nov24.webp?t=1731451788" type="image/jpeg" medium="image" fileSize="295649">
        <media:title type="plain">~Momentis Surgical Anovo robotic platform</media:title>
        <media:description type="plain">Momentis Surgical Anovo robotic platform. Credit: Momentis Surgical</media:description>
      </media:content>
    </item>
    <item>
      <title>Zap Surgical gathers in $78M series E funding round</title>
      <author>holland.johnson@clarivate.com</author>
      <description>
        <![CDATA[Zap Surgical Systems Inc. reported closing a $78 million series E funding round led by Qingdao Baheal Medical Inc., with participation from other strategic investors. The new funds will be used to commercialize the company’s Zap-X gyroscopic radiosurgery platform for the non-invasive treatment of brain tumors.]]>
      </description>
      <guid>http://www.bioworld.com/articles/714027</guid>
      <pubDate>Mon, 11 Nov 2024 11:00:00 -0500</pubDate>
      <link>https://www.bioworld.com/articles/714027-zap-surgical-gathers-in-78m-series-e-funding-round</link>
      <media:content url="https://www.bioworld.com/ext/resources/BMT-source/2024/Zap-Surgical-11nov24.webp?t=1731359119" type="image/jpeg" medium="image" fileSize="306851">
        <media:title type="plain">Zap Surgical</media:title>
        <media:description type="plain">Zap-X gyroscopic radiosurgery platform at Hacettepe University Hospital in Ankara, Turkey. Credit: Zap</media:description>
      </media:content>
    </item>
  </channel>
</rss>
